Clinical Trial Update: Efficacy of Neoadjuvant Chemotherapy in Terms of DFS in Patients With Localized Digestive Neuroendocrine Carcinomas [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant chemotherapy trial in patients with localized digestive neuroendocrine carcinomas, currently recruiting, assessing disease-free survival.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digestive System Neoplasms
• Neuroendocrine Carcinoma

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Neuroendocrine Carcinoma, Digestive Cancer | Phase 2 | Status: RECRUITING